Annual SG&A
$2.52 M
+$434.60 K+20.84%
31 December 2023
Summary:
Bone Biologics annual selling, general & administrative expenses is currently $2.52 million, with the most recent change of +$434.60 thousand (+20.84%) on 31 December 2023. During the last 3 years, it has risen by +$1.50 million (+146.87%). BBLG annual SG&A is now -71.39% below its all-time high of $8.81 million, reached on 31 December 2016.BBLG Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$521.30 K
+$62.10 K+13.52%
30 September 2024
Summary:
Bone Biologics quarterly selling, general & administrative expenses is currently $521.30 thousand, with the most recent change of +$62.10 thousand (+13.52%) on 30 September 2024. Over the past year, it has dropped by -$191.60 thousand (-26.88%). BBLG quarterly SG&A is now -88.65% below its all-time high of $4.59 million, reached on 31 December 2015.BBLG Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$328.74 M
-$4.14 M-1.28%
30 September 2024
Summary:
Bone Biologics TTM selling, general & administrative expenses is currently -$328.74 million, with the most recent change of -$4.14 million (-1.28%) on 30 September 2024. Over the past year, it has dropped by -$331.26 million (-13143.26%). BBLG TTM SG&A is now -1168.55% below its all-time high of $11.11 million, reached on 30 June 2016.BBLG TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBLG Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -26.9% | -10000.0% |
| 3 y3 years | +146.9% | +22.4% | -10000.0% |
| 5 y5 years | +86.4% | +149.1% | -10000.0% |
BBLG Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +146.9% | -30.0% | +22.4% | -17.5% | at low |
| 5 y | 5 years | at high | +420.4% | -30.0% | >+9999.0% | -24.3% | at low |
| alltime | all time | -71.4% | +420.4% | -88.7% | >+9999.0% | -1168.5% | at low |
Bone Biologics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $521.30 K(+13.5%) | $2.35 M(+0.7%) |
| June 2024 | - | $459.20 K(-30.2%) | $2.34 M(-10.9%) |
| Mar 2024 | - | $657.90 K(-7.7%) | $2.62 M(+4.0%) |
| Dec 2023 | $2.52 M(+20.8%) | $712.90 K(+40.9%) | $2.52 M(+7.8%) |
| Sept 2023 | - | $506.00 K(-32.0%) | $2.34 M(+2.5%) |
| June 2023 | - | $744.60 K(+33.7%) | $2.28 M(+14.7%) |
| Mar 2023 | - | $556.90 K(+4.8%) | $1.99 M(-4.6%) |
| Dec 2022 | $2.09 M(+104.3%) | $531.20 K(+18.1%) | $2.09 M(+5.3%) |
| Sept 2022 | - | $449.90 K(-0.4%) | $1.98 M(+12.5%) |
| June 2022 | - | $451.70 K(-30.8%) | $1.76 M(+14.4%) |
| Mar 2022 | - | $653.10 K(+53.3%) | $1.54 M(+50.7%) |
| Dec 2021 | $1.02 M(+110.8%) | $426.00 K(+85.4%) | $1.02 M(+30.9%) |
| Sept 2021 | - | $229.80 K(-0.0%) | $779.80 K(+41.0%) |
| June 2021 | - | $229.90 K(+69.8%) | $552.90 K(+23.8%) |
| Mar 2021 | - | $135.40 K(-26.7%) | $446.70 K(-7.7%) |
| Dec 2020 | $484.30 K(-64.2%) | $184.70 K(+6269.0%) | $484.20 K(-4.8%) |
| Sept 2020 | - | $2900.00(-97.7%) | $508.80 K(-33.3%) |
| June 2020 | - | $123.70 K(-28.5%) | $762.30 K(-15.3%) |
| Mar 2020 | - | $172.90 K(-17.4%) | $900.30 K(-33.4%) |
| Dec 2019 | $1.35 M | $209.30 K(-18.4%) | $1.35 M(-23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $256.40 K(-2.0%) | $1.77 M(-18.6%) |
| June 2019 | - | $261.70 K(-58.1%) | $2.17 M(-15.9%) |
| Mar 2019 | - | $624.90 K(-0.0%) | $2.58 M(-3.8%) |
| Dec 2018 | $2.69 M(-32.1%) | $625.10 K(-5.4%) | $2.69 M(-11.2%) |
| Sept 2018 | - | $660.90 K(-1.8%) | $3.03 M(-7.2%) |
| June 2018 | - | $672.70 K(-7.6%) | $3.26 M(-12.3%) |
| Mar 2018 | - | $727.70 K(-24.6%) | $3.72 M(-6.1%) |
| Dec 2017 | $3.96 M(-55.1%) | $965.50 K(+7.7%) | $3.96 M(-39.7%) |
| Sept 2017 | - | $896.50 K(-20.7%) | $6.57 M(-6.9%) |
| June 2017 | - | $1.13 M(+16.7%) | $7.06 M(-10.6%) |
| Mar 2017 | - | $968.80 K(-72.9%) | $7.90 M(-10.4%) |
| Dec 2016 | $8.81 M(+5.8%) | $3.57 M(+158.2%) | $8.81 M(-10.4%) |
| Sept 2016 | - | $1.38 M(-29.7%) | $9.83 M(-11.5%) |
| June 2016 | - | $1.97 M(+4.7%) | $11.11 M(+17.2%) |
| Mar 2016 | - | $1.88 M(-59.0%) | $9.48 M(+13.8%) |
| Dec 2015 | $8.33 M(+451.9%) | $4.59 M(+72.3%) | $8.33 M(+122.9%) |
| Sept 2015 | - | $2.67 M(+694.3%) | $3.74 M(+249.0%) |
| June 2015 | - | $335.60 K(-54.3%) | $1.07 M(+45.7%) |
| Mar 2015 | - | $735.10 K | $735.10 K |
| Dec 2014 | $1.51 M | - | - |
FAQ
- What is Bone Biologics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bone Biologics?
- What is Bone Biologics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bone Biologics?
- What is Bone Biologics quarterly SG&A year-on-year change?
- What is Bone Biologics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bone Biologics?
- What is Bone Biologics TTM SG&A year-on-year change?
What is Bone Biologics annual selling, general & administrative expenses?
The current annual SG&A of BBLG is $2.52 M
What is the all time high annual SG&A for Bone Biologics?
Bone Biologics all-time high annual selling, general & administrative expenses is $8.81 M
What is Bone Biologics quarterly selling, general & administrative expenses?
The current quarterly SG&A of BBLG is $521.30 K
What is the all time high quarterly SG&A for Bone Biologics?
Bone Biologics all-time high quarterly selling, general & administrative expenses is $4.59 M
What is Bone Biologics quarterly SG&A year-on-year change?
Over the past year, BBLG quarterly selling, general & administrative expenses has changed by -$191.60 K (-26.88%)
What is Bone Biologics TTM selling, general & administrative expenses?
The current TTM SG&A of BBLG is -$328.74 M
What is the all time high TTM SG&A for Bone Biologics?
Bone Biologics all-time high TTM selling, general & administrative expenses is $11.11 M
What is Bone Biologics TTM SG&A year-on-year change?
Over the past year, BBLG TTM selling, general & administrative expenses has changed by -$331.26 M (-13143.26%)